HUBRAGO

Welcome to the Brand page for “HUBRAGO”, which is offered here for Pharmaceutical preparations for the treatment of central nervous system disorders; pharmaceutical preparations for the treatment of peripheral nervous system disorders; pharmaceutical preparations for the treatment of growth deficiencies; pharmaceutical preparations for the treatment of enzyme deficiencies; pharmaceutical preparations for the treatment of lysosomal storage diseases; pharmaceutical preparations for the treatment of fabry disease, gaucher disease, gm1 gangliosidosis, gm2 gangliosidosis, krabbe disease, niemann-pick disease, metachromatic leukodystrophy, hurier syndrome, hunter disease, sanfilippo syndrome, morquio syndrome, sly syndrome, pompe disease, alfa-mannosidosis disease, fucosidosis disease, and neuronal ceroid lipofuscinosis;.

Its status is currently believed to be active. Its class is unavailable. “HUBRAGO” is believed to be currently owned by “JCR PHARMACEUTICALS CO., LTD.”